Altimmune, Inc. (ALT)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $111k
- Aug 19 · No plan
- Form 4 sales
- 30
- On record
- Form 144 notices
- 0
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleUnusualJun 27 2022
Sold 37,352 shares at $12.00 ($448k)
Roberts M Scot, Chief Scientific Officer
Sold 67.8% of holdings ($661k position)17,700 shares leftFirst sale on recordFiling
- 2 Form 4 salePlan not statedJun 29 +2 days
Sold 5,462 shares at $12.00 ($66k)
Roberts M Scot, Chief Scientific Officer
Sold 23.6% of holdings ($278k position)17,700 shares leftFiling
- 3 Form 4 saleUnusualJul 5 +6 days
Sold 37,164 shares at $12.00 ($446k)
Roberts M Scot, Chief Scientific Officer
Sold 81.7% of holdings ($546k position)8,305 shares leftFiling
- 4 Form 4 salePlan not statedAug 12 +38 days
Sold 15,000 shares at $15.06 ($226k)
Garg Vipin K, President and CEO
Sold 5.5% of holdings ($4.1M position)259,804 shares leftFirst sale on recordFiling
- 5 Form 4 saleUnusualAug 12 same day
Sold 2,714 shares at $15.00 ($41k)
Gill John, Director
No 10b5-1 planSold 49.5% of holdings ($82k position)2,771 shares leftFiling
- 6 Form 4 salePlan not statedAug 31 +19 days
Sold 20,000 shares at $20.02 ($400k)
Garg Vipin K, President and CEO
Sold 7.8% of holdings ($5.1M position)236,797 shares leftFiling
- 7 Form 4 saleUnusualDec 22 +113 days
Sold 20,000 shares at $15.01 ($300k)
Pisano Wayne, Director
Sold 70.2% of holdings ($428k position)8,498 shares leftFirst sale on recordFiling
- 8 Form 4 saleNo planAug 19 +606 days
Sold 16,011 shares at $6.90 ($111k)
Drutz David, Director
No 10b5-1 planSold 22.4% of holdings ($494k position)55,524 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales, notices and lockups (30)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Aug 19, 2024 | Drutz David | Director | Form 4 sale | 16,011 | $111k | 22.4% | No plan | SEC |
| Dec 22, 2022 | Pisano Wayne | Director | Form 4 sale | 20,000 | $300k | 70.2% | Unusual | SEC |
| Aug 31, 2022 | Garg Vipin K | President and CEO | Form 4 sale | 20,000 | $400k | 7.8% | Plan not stated | SEC |
| Aug 12, 2022 | Gill John | Director | Form 4 sale | 2,714 | $41k | 49.5% | Unusual | SEC |
| Aug 12, 2022 | Garg Vipin K | President and CEO | Form 4 sale | 15,000 | $226k | 5.5% | Plan not stated | SEC |
| Jul 5, 2022 | Roberts M Scot | Chief Scientific Officer | Form 4 sale | 37,164 | $446k | 81.7% | Unusual | SEC |
| Jun 29, 2022 | Roberts M Scot | Chief Scientific Officer | Form 4 sale | 5,462 | $66k | 23.6% | Plan not stated | SEC |
| Jun 27, 2022 | Roberts M Scot | Chief Scientific Officer | Form 4 sale | 37,352 | $448k | 67.8% | Unusual | SEC |
| Jun 27, 2022 | Jorkasky Diane | Director | Form 4 sale | 17,610 | $207k | 100.0% | Unusual | SEC |
| Feb 28, 2022 | Harris Matthew Scott | Chief Medical Officer | Form 4 sale | 30,000 | $226k | 72.2% | Unusual | SEC |
| Mar 1, 2021 | Hodges Philip | Director | Form 4 sale | 6,000 | $96k | 40.7% | Unusual | SEC |
| Dec 1, 2020 | Hodges Philip | Director | Form 4 sale | 3,727 | $47k | 20.2% | Plan not stated | SEC |
| Nov 30, 2020 | Gill John | Director | Form 4 sale | 8,425 | $100k | 42.9% | Unusual | SEC |
| Nov 12, 2020 | Schafer Klaus | Director | Form 4 sale | 10,150 | $101k | 59.5% | Unusual | SEC |
| Nov 12, 2020 | Pisano Wayne | Director | Form 4 sale | 10,352 | $102k | 54.9% | Unusual | SEC |
| Nov 12, 2020 | Harris Matthew Scott | Director | Form 4 sale | 4,015 | $40k | 49.7% | Unusual | SEC |
| May 15, 2020 | Velocity Pharmaceutical Holdings LLC | 10% owner | Form 4 sale | 200,000 | $957k | 10.6% | Plan not stated | SEC |
| Dec 9, 2016 | Prescott Group Capital Management, L.L.C. | 10% owner | Form 4 sale | 1.4M | $4.4M | 17.0% | Plan not stated | SEC |
| Apr 13, 2016 | Richman Eric I | Director | Form 4 sale | 329,354 | $725k | 65.1% | Unusual | SEC |
| Apr 8, 2016 | Richman Eric I | Director | Form 4 sale | 11,767 | $26k | 6.2% | Plan not stated | SEC |
| Jan 7, 2015 | Chang Linda L | SVP, CFO & Secretary | Form 4 sale | 29,600 | $62k | 49.7% | Unusual | SEC |
| May 31, 2011 | Riddle Valerie D | SVP, Medical Director | Form 4 sale | 13,567 | $53k | 23.4% | Plan not stated | SEC |
| May 25, 2011 | Pappajohn John | Director | Form 4 sale | 50,000 | $184k | 11.3% | Plan not stated | SEC |
| May 23, 2011 | Riddle Valerie D | SVP, Medical Director | Form 4 sale | 8,791 | $32k | 15.0% | Plan not stated | SEC |
| May 19, 2011 | Schaffer Derace L | Director | Form 4 sale | 267,497 | $987k | 18.7% | Plan not stated | SEC |
| Mar 26, 2009 | Pappajohn John | Director | Form 4 sale | 17,735 | 2.4% | Plan not stated | SEC | |
| Mar 26, 2009 | Schaffer Derace L | Director | Form 4 sale | 17,735 | 2.9% | Plan not stated | SEC | |
| Mar 12, 2009 | Schaffer Derace L | Director | Form 4 sale | 212,814 | 25.9% | Unusual | SEC | |
| Mar 12, 2009 | Pappajohn John | Director | Form 4 sale | 212,814 | 22.6% | Plan not stated | SEC | |
| Aug 3, 2007 | Millennium Management, L.L.C. | 10% owner | Form 4 sale | 215,500 | $1.3M | 18.0% | Plan not stated | SEC |